Multi-chamber cardioids unravel human heart development and cardiac defects
- PMID: 38029745
- DOI: 10.1016/j.cell.2023.10.030
Multi-chamber cardioids unravel human heart development and cardiac defects
Abstract
The number one cause of human fetal death are defects in heart development. Because the human embryonic heart is inaccessible and the impacts of mutations, drugs, and environmental factors on the specialized functions of different heart compartments are not captured by in vitro models, determining the underlying causes is difficult. Here, we established a human cardioid platform that recapitulates the development of all major embryonic heart compartments, including right and left ventricles, atria, outflow tract, and atrioventricular canal. By leveraging 2D and 3D differentiation, we efficiently generated progenitor subsets with distinct first, anterior, and posterior second heart field identities. This advance enabled the reproducible generation of cardioids with compartment-specific in vivo-like gene expression profiles, morphologies, and functions. We used this platform to unravel the ontogeny of signal and contraction propagation between interacting heart chambers and dissect how mutations, teratogens, and drugs cause compartment-specific defects in the developing human heart.
Keywords: cardiac defects; cardiac organoids; cardioids; congenital heart disease; congenital mutations; drug screening; heart development; multi-chamber; teratogens.
Copyright © 2023 IMBA-Institut für Molekulare Biotechnologie GmbH. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The IMBA filed a patent application (Nr.21712188.8) on multi-chamber cardioids with C.S., A.D., T.I., and S.M. named as inventors. P.H. and S.M. are co-founders, and S.M. is a SAB member of HeartBeat.bio AG, the IMBA cardioid drug discovery platform spin-off.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical